Charles Schwab
SLS icon

Charles Schwab’s SELLAS Life Sciences SLS Stock Holding History

Charles Schwab’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.34M Buy
565,008
+84,404
+18% +$583K ﹤0.01% 2243
2026
Q1 		$2.03M Buy
480,604
+72,203
+18% +$323K ﹤0.01% 2718
2025
Q4 		$1.54M Buy
408,401
+114,295
+39% +$222K ﹤0.01% 2803
2025
Q3 		$474K Hold
294,106
– – ﹤0.01% 3193
2025
Q2 		$644K Buy
294,106
+277,868
+1,711% +$426K ﹤0.01% 3042
2025
Q1 		$17.5K Hold
16,238
– – ﹤0.01% 3464
2024
Q4 		$16.9K Hold
16,238
– – ﹤0.01% 3489
2024
Q3 		$20.3K Hold
16,238
– – ﹤0.01% 3484
2024
Q2 		$19.3K Hold
16,238
– – ﹤0.01% 3591
2024
Q1 		$16.4K Hold
16,238
– – ﹤0.01% 3442
2023
Q4 		$17.2K Hold
16,238
– – ﹤0.01% 3498
2023
Q3 		$26.6K Hold
16,238
– – ﹤0.01% 3482
2023
Q2 		$25.5K Hold
16,238
– – ﹤0.01% 3526
2023
Q1 		$23.2K Hold
16,238
– – ﹤0.01% 3489
2022
Q4 		$38.3K Hold
16,238
– – ﹤0.01% 3412
2022
Q3 		$33K Buy
+16,238
New +$44.8K ﹤0.01% 3414
2017
Q2 		– Sell
-9
Closed -$9K – 3131
2017
Q1 		$9K Hold
9
– – ﹤0.01% 3055
2016
Q4 		$26K Buy
+9
New +$52.3K ﹤0.01% 3072

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Charles Schwab's SLS Position: Q2 2026 in Review

Charles Schwab increased its SELLAS Life Sciences (SLS) stake by 18% in Q2 2026, buying an estimated $583K and bringing the position to 565,008 shares worth $8.34M. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

Charles Schwab first reported a position in SLS in Q4 2016 and has held it in 18 quarters since. 191 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Charles Schwab held 565,008 shares of SELLAS Life Sciences worth $8.34M as of Q2 2026.
  • Charles Schwab bought 84,404 SELLAS Life Sciences shares in Q2 2026, an estimated $583K.
  • SELLAS Life Sciences made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2243 holding.
  • Charles Schwab first reported a position in SELLAS Life Sciences in Q4 2016 and has held it in 18 quarters since.
  • 191 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.